About MEDESIS PHARMA S.A.
Sector
Industry
CEO
Jean-Claude Maurel
Website
Headquarters
Baillargues
Founded
2003
ISIN
FR0010844464
FIGI
BBG00Z1FPLX7
Medesis Pharma SA operates as a clinical development stage biopharmaceutical company, which engages in the research and development of orally administered molecule drugs. The company was founded by Jean-Claude Maurel on April 3, 2004, and is headquartered in Baillargues, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ALMDP is 1.570 EUR — it has increased by 9.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange MEDESIS PHARMA S.A. stocks are traded under the ticker ALMDP.
ALMDP stock is 9.67% volatile and has beta coefficient of 0.27. Check out the list of the most volatile stocks — is MEDESIS PHARMA S.A. there?
One year price forecast for MEDESIS PHARMA S.A. has a max estimate of 3.300 EUR and a min estimate of 3.300 EUR.
Yes, you can track MEDESIS PHARMA S.A. financials in yearly and quarterly reports right on TradingView.
ALMDP stock has risen by 16.30% compared to the previous week, the month change is a 12.78% fall, over the last year MEDESIS PHARMA S.A. has showed a 31.74% decrease.
No, ALMDP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALMDP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDESIS PHARMA S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDESIS PHARMA S.A. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDESIS PHARMA S.A. stock shows the neutral signal. See more of MEDESIS PHARMA S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MEDESIS PHARMA S.A. future price: according to them, ALMDP price has a max estimate of 3.30 EUR and a min estimate of 3.30 EUR. Read a more detailed MEDESIS PHARMA S.A. forecast: see what analysts think of MEDESIS PHARMA S.A. and suggest that you do with its stocks.